The overall positive results in cAS, particularly head and neck, are consistent with its known biomarkers of response to ICI such as TMB-High, PD-L1 positivity, UV mutational signature, and presence of TILs in the tumor microenvironment. This evidence concerns the gene CD274 and neoplasm.